In March 2025, the company announced new designs for any immediate-to-consumer providing of its Wegovy weight loss drug. The company proven a different pharmacy, termed NovoCare, which might demand customers $499 every month for usage of the drug, lower than fifty percent the cost of the drug by way of other pharmaceutical distribution networks.[53